[...] of access to health. For example, we are expanding our research program within the scope of our Praziquantel Donation Program, a partnership with the World Health Organization (WHO) to combat the worm disease schistosomiasis. We are now working to develop a pediatric tablet formulation for preschool children, a previously untreated age group. Furthermore, we plan to establish an overall management process for access to health. The Corporate Responsibility Committee has decided to develop a comprehensive human rights policy. The aim is to increase awareness of the topic within Merck KGaA, Darmstadt, Germany and to identify company-specific risks more accurately. [...]